Boala Parkinson și tulburări de mișcare.
64 de articoleResearchers at Texas A&M University developed a novel mouse model using Theiler's murine encephalomyelitis virus (TMEV) infection to generate Parkinson's disease symptoms without genetic modification or toxic injection. This approach provides a more naturalistic animal model to investigate the hypothesis that viral infection may trigger Parkinson's disease development in humans.
This study used corneal confocal microscopy to detect corneal nerve loss as a potential biomarker for neurodegeneration in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Corneal nerve fiber density was significantly reduced in all three patient groups compared to healthy controls, with the most pronounced changes in multiple system atrophy, suggesting this imaging technique may help differentiate these neurodegenerative conditions.
Rhythmic auditory stimulation (RAS) demonstrates effectiveness in improving gait, balance, and fall prevention in Parkinson's disease through mechanisms involving neural entrainment and oscillatory brain coupling. Research suggests RAS-based interventions may address additional PD symptoms and extend to atypical parkinsonian disorders, though further study is warranted.
UCLA researchers found that long-term exposure to the pesticide chlorpyrifos significantly increases Parkinson's disease risk, with exposed individuals showing more than twice the likelihood of developing the condition. Laboratory studies demonstrated the chemical damages dopamine neurons and impairs the brain's ability to clear toxic protein aggregates.
Research presented at the European Academy of Neurology Congress 2026 reveals that women with Parkinson's disease may experience greater Alzheimer's-related pathological changes in the brain than men. The study addresses a gap in understanding sex-based differences in co-occurring neurodegenerative pathology among older adults with Parkinson's disease.
Researchers developed a method to identify which genetic networks discovered in model organisms (yeast, neurons, mice) are most relevant to human Parkinson's disease. This translational genetics approach bridges the gap between basic research findings and actual human disease mechanisms.
